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Abstract 
Objective. This study investigated the effectiveness of an innovative, manualized 
psychotherapy aimed at enhancing recovery and self-experience in people with schizophrenia, 
Metacognitive Narrative Psychotherapy.  
Design. Treatment effects were assessed using a mixed methodology. Data were 
quantitatively assessed using a single sample, pre- and post-therapy design and qualitatively 
assessed using a case-study methodology.  
Methods. Eleven patients diagnosed with schizophrenia received Metacognitive Narrative 
Psychotherapy over the course of 11 to 26 months. Therapists were seven supervised 
postgraduate psychology students. On average patients attended 49 sessions over the course 
of therapy. Patients completed interview-based and self-report measures for general and 
treatment-specific outcomes at pre-, mid-, and post-treatment.  
Results. Quantitative analyses showed that patients significantly improved on the general 
outcome of subjective recovery, as well as the treatment-specific outcome of self-reflectivity, 
with medium to large effect sizes. Case-study evidence also showed improvements for some 
patients in symptom severity, and narrative coherence and complexity. 
Conclusions. These results are consistent with previous case-study evidence and suggest that 
this manualized version of Metacognitive Narrative Psychotherapy produces general and 
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approach-specific improvements for people with schizophrenia. Replication is needed to 
ascertain its effectiveness with a larger sample size and within a controlled design. 
3 
Practitioner’s Points  
1. People with psychotic symptoms experience disruptions in self-disturbance which are 
amenable to psychological interventions. 
2. A focus on enhancing metacognitive capacity in people with psychotic symptoms may 
contribute to enhancing sense of recovery.  
3. The current findings support the use of interventions that target capacity for 
meaningful storytelling in people with psychotic symptoms.  
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Psychotherapy for people diagnosed with schizophrenia has a long and controversial 
history. While it was the treatment of choice in the mid-20th Century, it came into disfavor in 
the late 1980s with a growing emphasis on neurobiological causes of schizophrenia and the 
introduction of second-wave antipsychotic medication. For the past 20 to 30 years the use of 
medication has dominated mainstream approaches to the treatment of psychotic disorders 
with little credibility or resources being allocated to psychological interventions. However, 
more recently, interest in psychological interventions aimed at ameliorating the impact of 
psychosis on the lives of individuals has increased. Current research evidence shows that 
psychological interventions including cognitive-behavioural, psychodynamic, and dialogical 
approaches to psychotherapy are effective in the treatment of people diagnosed with 
schizophrenia, both in the early and chronic stages of the disorder (Lysaker, Buck, & Ringer, 
2007; Rosenbaum et al., 2012; Wykes, Steel, Everitt, & Tarrier, 2008; Yung et al., 2011).  
Reignited interest in psychotherapy for people with schizophrenia has occurred within 
the context of a growing emphasis in mental health services on recovery from severe mental 
illness and advances in the phenomenological understanding of schizophrenia (Bellack, 2006; 
Davidson, 2003; Sass & Parnas, 2001). Recovery from mental illness is “a deeply personal, 
unique process [which] ... involves the development of new meaning and purpose as one 
grows beyond the catastrophe of mental illness” (Anthony, 1993, p. 527). Recovery is no 
longer viewed solely in terms of symptom cessation. Instead, recovery incorporates two 
specific domains: objective and subjective recovery (Bellack, 2006; Lysaker & Buck, 2008). 
The objective aspects of recovery relate to the reduction of illness-related problems while the 
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subjective aspects of recovery relate to a person’s subjective experience of their life 
and mental health difficulties. Research suggests a bi-directional relationship between 
objective and subjective aspects of recovery, linking objective measures of recovery 
such as paid employment and symptom severity, with subjective aspects such as 
empowerment, self-experience, quality of life, and hope (Lloyd, King, & Moore, 
2010; Lysaker, Buck, Hammoud, Taylor, & Roe, 2006).  While 
psychopharmacotherapy and vocational rehabilitation focus on the objective aspects of 
recovery from psychosis, there has been a lack of interventions that address sufferers’ 
sense of self and subjective experiences of their difficulties. 
Recognizing the centrality of sense of self and human subjectivity in the 
recovery process for people with psychotic symptoms, Lysaker and colleagues 
(Lysaker et al., 2011) developed Metacognitive Narrative Psychotherapy, an 
adaptation of a psychotherapeutic approach to the treatment of personality disorders 
(Dimaggio et al., 2012; Dimaggio, Semerari, Carcione, Nicolò, & Procacci, 2007). 
Metacognitive Narrative Psychotherapy draws upon dialogical narrative 
understandings of self-experience and schizophrenia, and is influenced by 
multidimensional conceptualizations of recovery from mental illness (Lysaker & 
Buck, 2008; Lysaker, Lysaker, & Lysaker, 2001). The approach was also designed to 
specifically target impaired metacognitive capacity, recognizing it as a stable and 
independent feature of schizophrenia, which is linked to increased symptom severity 
and poor social functioning (Brune, Dimaggio, & Lysaker, 2011; Harrington, 
Langdon, Siegert, & McClure, 2005; Lysaker, Carcione, et al., 2005; Lysaker et al., 
2009; Lysaker & Lysaker, 2004; Nicolò et al., 2012; Roncone et al., 2002).  
Metacognition refers to a spectrum of activities which involves thinking about 
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thinking and stretches from consideration of discrete psychological phenomenon to the 
synthesis of discrete perception into an integrated representation of self and others (Lysaker, 
et al., 2011). 
Case-study evidence has demonstrated that the approach yields positive effects on 
metacognitive capacity, narrative structure and content, quality of life, symptom severity, and 
insight in the treatment of people with schizophrenia (Buck & Lysaker, 2009; Lysaker, et al., 
2007; Lysaker, Davis, et al., 2005; Lysaker & Hermans, 2007; Salvatore et al., 2012; 
Salvatore et al., 2009). Metacognitive Narrative Psychotherapy is also the only intervention to 
date, with the exception of a case study of mentalization-based therapy (Brent, 2009), that has 
been designed specifically to target metacognitive deficits in people with schizophrenia.  
However, there is little evidence that the approach developed and described by Lysaker and 
colleagues is generalizable across settings. Further trials are needed to confirm the initial 
case-study reports of the effectiveness of the intervention. 
The current study expands upon earlier research conducted by Lysaker and colleagues 
(Lysaker, et al., 2011; Lysaker, et al., 2007; Lysaker, Davis, et al., 2005), by investigating the 
effectiveness of a manualised version of Metacognitive Narrative Psychotherapy in the 
treatment of 11 people diagnosed with schizophrenia. The study attempts to overcome the 
challenges of working with a small sample by adopting a mixed methodology. The current 
paper has two objectives: (1) assess data quantitatively using a single-sample, pre- and post-
treatment design, and (2) explore data qualitatively using a case-study methodology. Patients 
were expected to show improvement in general outcomes: subjective sense of recovery and 
symptom severity, and in treatment-specific dimensions: metacognitive capacity, narrative 
coherence, and narrative complexity. 
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Method 
Participants 
Nineteen people were interviewed, and 18 met inclusion criteria. Fourteen people 
commenced treatment and three dropped-out, on average after 16 sessions. The mean age of 
the 11 people who completed treatment was 45.45 years. Nine were male, two were female. 
Three patients were employed, two were students, and six were unemployed. Most patients 
were single and childless. One patient was married, one divorced, and two had children. Ten 
patients were taking antipsychotic medication. Patient inclusion criteria were: (1) diagnosed 
with schizophrenia or schizoaffective disorder consistent with DSM-IV criteria, (2) 
medication unchanged for two months prior to commencement of therapy, (3) no 
hospitalisations for two months prior to commencement of therapy, (4) able to provide 
informed consent. Exclusion criteria included intellectual disability, and high risk of suicide 
or harming others. 
 
Recruitment 
Participants were recruited from non-government organizations, local psychiatrists 
and General Practitioners, and the Australian Schizophrenia Research Bank (ASRB). The first 
point of contact was in the form of an email or letter, with a face-to-face meeting and 
presentation following this. 
 
 
Measures 
Clinical Diagnosis. Diagnoses were assessed using the Psychotic Symptoms and 
Psychotic Disorders sections of the Structured Clinical Interview for DSM-IV Axis I 
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Disorders (SCID-I). The SCID-I is a semi-structured, diagnostic clinical interview. The 
Psychotic Symptoms and Psychotic Disorders sections of the SCID-I focus on the presence of 
psychotic symptoms, and the differentiation and diagnosis of psychotic spectrum disorders. 
This measure has good inter-rater reliability (Lobbestael, Leurgans, & Arntz, 2011).  
Recovery Assessment Scale (RAS). The RAS is a 41-item, self-report questionnaire 
used to measure degree of recovery from mental illness (Corrigan, Giffort, Rashid, Leary, & 
Okeke, 1999). It assesses different aspects of recovery using a 5-point Likert scale. Items 
include, “I have a desire to succeed”; “I have my own plan for how to stay or become well” 
and “I can handle it if I get sick again”. An exploratory factor analysis and confirmatory 
factor analysis conducted on the RAS yielded five factors: Personal Confidence and Hope, 
Willingness to Ask for Help, Goal and Success Orientation, Reliance on Others, and Non 
Domination by Symptoms (Corrigan, Salzer, Ralph, Sangster, & Keck, 2004). An Australian 
study found each factor to have satisfactory internal reliability (Cronbach α range = 0.73 – 
0.91) and convergent validity with positive and significant correlations with other recovery 
measures (McNaught, Caputi, Oades, & Deane, 2007).  
Brief Psychiatric Rating Scale – Extended (BPRS). The BPRS is an instrument 
used to measure the severity of 24 psychiatric symptoms (Lukoff, Liberman, & Nuechterlein, 
1986). Scoring of the BPRS is based on a 10 to 30 minute interview. Each of the 24 
symptoms is rated on a 7-point scale, with a higher rating indicating greater symptom severity 
(1 = not present; 7 = extremely severe). A total score is derived by adding the scores for all 
items. Exploratory and confirmatory factor analyses conducted on the BPRS yielded four 
factors: Thought Disturbance, Apathy, Animation, and Mood Disturbance (Thomas, Donnell, 
& Young, 2004). Research has linked BPRS scores to Clinical Global Impression (CGI) 
ratings, with ‘mildly ill’ corresponding to a BPRS total score of 31, ‘moderately ill’ to a 
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BPRS score of 41, and ‘markedly ill’ to a BPRS score of 53 (Leucht et al., 2005). The BPRS 
has good inter-rater reliability (ICC = 0.85; Earnshaw, Rees, Dunn, & Burlingame, 2005). 
Indiana Psychiatric Illness Interview (IPII). The IPII is a semi-structured interview 
designed to elicit life and illness narratives (Lysaker, Clements, Plascak-Hallberg, 
Knipscheer, & Wright, 2002). The interview comprises five sections and takes between 30 
and 60 minutes to complete. The sections are general free narrative; illness narrative; what’s 
wrong versus what’s not wrong; degree of influence of illness construct; and the future, 
hopefulness and satisfaction. For example, the leading question is, “I'd like you to tell me the 
story of your life in as much detail as you can from as early as you can remember up until 
now". 
Narrative Coherence Rating Scale (NCRS). The NCRS measures degree of 
narrative coherence based on an IPII transcript (Lysaker, et al., 2002). The NCRS, completed 
by a trained rater using scoring anchors, consists of six items scored between zero and three. 
Three general scores are generated: Logical Connections, Richness of Historical Detail, and 
Plausibility, and then summed to create a total score (range = 0 – 18). Higher scores indicate 
greater narrative coherence. The NCRS has good internal consistency (Coefficient Alpha = 
0.88) and good to excellent inter-rater reliability (Intraclass correlations (ICC) range = 0.81 – 
0.95; Lysaker, et al., 2002). In the current study excellent inter-rater reliability was achieved 
(Total Score ICC = 0.93). 
Scale to Assess Narrative Development (STAND). The STAND measures narrative 
complexity based on an IPII transcript. The scale comprises four subscales: Social Worth, 
Social Connectedness, Personal Agency, and Illness Conception (Lysaker, Wickett, 
Campbell, & Buck, 2003). It is completed by a trained rater using scoring anchors. Subscale 
scores are used to generate a total score (range = 4 – 20). Higher scores indicate greater 
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narrative complexity. The STAND subscale scores and total score have good to excellent 
inter-rater reliability (ICC range = 0.82 – 0.94) and good internal consistency (Coeffecient 
Alpha = 0.85; Lysaker, et al., 2003). In the current study excellent inter-rater reliability was 
achieved (Total Score ICC = 0.94). 
Metacognitive Assessment Scale – Self-Reflectivity Subscale (MAS-SR). The 
MAS-SR was used to assess capacity to reflect upon one’s own mental states (Lysaker, 
Carcione, et al., 2005; Semerari et al., 2003).  The MAS measures metacognitive capacity and 
assumes it varies along a continuum from less to more complex metacognitive acts. The 
MAS-SR consists of nine metacognitive acts. Raters read IPII transcripts and indicate whether 
the participant has used or failed to use a metacognitive function. Full presence of a function 
is rated ‘1’ and partial presence of a function is rated ‘0.5’. Item scores are summed to provide 
a total score (range = 0 – 9). The MAS-SR has been found to have good inter-rater reliability 
(ICC = 0.89; Lysaker, et al., 2005).  The current study also found good inter-rater reliability 
for the MAS-SR (ICC = 0.76).  
 
Therapists 
Therapists comprised seven female, Caucasian psychologists with provisional 
registration. They were all enrolled in a clinical psychology postgraduate program approved 
by the Australian Psychology Accreditation Council (APAC). Their ages ranged from 25 to 
30. Therapists trained in the intervention over the course of two days and demonstrated 
competency in the model. Training involved gaining a comprehensive understanding of the 
manual, Metacognitive Narrative Psychotherapy for People with Schizophrenia: Guiding 
Principles and Practices (Bargenquast & Schweitzer, 2012). Therapists also attended 
fortnightly group supervision facilitated by the authors. Therapy sessions were video-recorded 
and randomly reviewed using the 18-item Metacognitive Narrative Psychotherapy Integrity 
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Schedule to assess therapist adherence to the principles outlined in the manual. Three to four 
sessions per patient were reviewed by the first author over the course of treatment, with a high 
degree of therapist adherence (M = 84.29%). 
 
Treatment Model 
Treatment was informed by a principle-based manual of Metacognitive Narrative 
Psychotherapy for people with schizophrenia (Bargenquast & Schweitzer, 2012). 
Metacognitive Narrative Psychotherapy aims to enhance self-experience in people with 
schizophrenia by targeting deficits in metacognitive capacity and ability to construct a 
coherent, complex, and meaningful narrative. The approach is integrative and draws upon 
narrative theory and recent research investigating metacognitive narrative approaches to the 
treatment of schizophrenia (Angus & McLeod, 2004; Lysaker, et al., 2011; see Figure 1).  
Insert Figure 1. 
Treatment comprised five phases: 1) Developing a therapeutic relationship, 2) 
Eliciting narratives, 3) Enhancing metacognitive capacity, 4) Enriching narratives, and 5) 
Living enriched narratives. While each phase of treatment consisted of specific treatment 
goals and techniques, sessions were not conducted in a prescriptive or rigid manner; they 
were tailored to the individual patient.  
The therapy program ran from September 2010 to November 2012, with participants 
recruited up until September 2011. Sessions were conducted face-to-face once per week. 
Therapists saw one to three patients each. Therapists and patients were matched based on 
schedule compatibility. The average total number of sessions was 49 and ranged from 25 to 
88. Average length of treatment was 15.82 months and ranged from 11 to 26 months.  
 
Procedure 
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Following ethical approval by the University Research Ethics Committee, patients 
provided informed consent. Treating psychiatrists were informed of their patient’s 
participation in the study. Prior to commencement of the treatment protocol, pre-intervention 
measures: demographic information form, IPII, RAS, and BPRS were administered by the 
first author. Interviews were video-recorded and later transcribed with identifying information 
removed. The IPII transcripts were then quantitatively rated by the first author using the 
NCRS, STAND, and MAS-SR. In addition, to assess inter-rater reliability, initial interviews 
were also rated by three graduate students who completed training in the administration of the 
measures and were blind to participant status. The same measures were re-administered at 
mid-treatment (M = 23 sessions, 6.8 months) for all but one patient, and at post-treatment for 
all patients. Patient names have been changed to maintain patient confidentiality. Male names 
have been used for all aliases.  
 
Results 
Quantitative 
Mean score plot graphs for outcome variables at pre-, mid-, and post-treatment 
revealed increased scores overtime on the RAS, NCRS, STAND, and MAS-SR. No change 
was observed on the BPRS. Repeated measure analyses of variance (ANOVAs) were 
calculated for the RAS, NCRS, STAND, and MAS-SR, followed by calculation of effect sizes 
using pooled standard deviations and correcting for dependence among means (Cohen, 1988; 
see Table 1).  
Insert Table 1. 
Positive treatment effects were indicated by significantly increased RAS scores with a 
large effect size, F(2, 20) = 6.75, p = .006, and significantly increased MAS-SR scores with a 
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medium effect size, F(2, 20) = 3.58, p = .047. Differences in mean scores on the NCRS and 
STAND were not significant (p = 0.296 and p = .095 respectively). However, effect sizes for 
the NCRS and STAND were medium to large (Cohen, 1988). 
 
Qualitative 
Case-study evidence is presented to further explore changes in RAS, BPRS, NCRS, 
STAND, and MAS-SR scores over the course of therapy. Patients were divided into four 
groups according to degree of change in RAS scores from pre- to post-treatment: 1) most 
improved, 2) improved, 3) unchanged, and 4) deteriorated (see Table 2).  
Insert Table 2. 
All but one patient displayed positive changes on one or more of the general outcome 
measures (RAS and BPRS) or specific outcome measures (NCRS, STAND, and MAS-SR). 
Eight patients showed a 6-point or greater increase in RAS scores from pre- to post-treatment. 
Decreases were found from pre- to post-treatment in BPRS Thought Disturbance scores for 
five patients, Mood Disturbance scores for two patients, and Apathy scores for one patient. 
Improvements were found from pre- to post-treatment in NCRS scores for six patients, 
STAND scores for nine patients, and MAS-SR scores for seven patients.  
Most Improved. Three patients were considered ‘most improved’: William, Orlando, 
and Bernard. Each had a 32-point or greater increase in their RAS scores from pre- to post-
treatment.  
William attended 42 therapy sessions. He initially presented with residual positive 
symptoms and mild negative symptoms. His overall symptom severity fell within the ‘mildly 
ill’ range at pre-treatment. William’s therapist experienced sessions as interesting; however, 
noticed initially that William lacked language to express his feelings, and was unable to 
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respond to questions such as, “What was that like for you?”.  She discovered that an in-
session focus on affect and labeling emotions helped William better identify how he felt and 
reflect on intersubjective processes during sessions. His engagement in therapy varied across 
his treatment. At times, William would request that he finish sessions early due to painful 
content being discussed. He also chose not to attend for one month towards the end of 
therapy, potentially due to difficulties managing the termination process. However, following 
reengagement in therapy, he described improvements in his capacity to hold a conversation 
and engage with others, and a sense of relief at having had the opportunity to put words to 
painful emotional experiences. William achieved improvements in narrative complexity and 
self-reflectivity over the course of therapy (STAND = +25%, MAS-SR = +14.3%; see Figure 
2). William also had decreased positive schizophrenia symptoms and depressive symptoms at 
post-treatment (BPRS Thought Disturbance = –30%; BPRS Mood Disturbance = –25%). He 
experienced no change in narrative coherence. 
Insert Figure 2. 
Orlando attended 57 therapy sessions. He presented with a relatively recent onset of 
schizophrenia, reporting that the diagnosis had been made five years previously. His symptom 
severity fell within the ‘mildly ill’ range at pre-treatment. Like William, Orlando’s capacity to 
engage in the therapeutic process varied. He initially struggled to talk with his therapist not 
allowing her space to think or speak. His therapist often experienced a feeling of isolation 
during sessions. With time, Orlando was more able to tolerate her reflections and developed 
some sense of her in his mind, e.g. he referred to her a number of times during his end-
treatment interview but not at all during his mid-treatment interview. During his final sessions 
Orlando appeared able to show his therapist she was important and their relationship was 
meaningful to him. At post-treatment, he had the highest RAS score in the study, indicating a 
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significant level of recovery. Orlando achieved a notable positive change in self-reflectivity 
and a modest improvement in narrative complexity (MAS-SR = +20%, STAND = +6.1%; see 
Figure 3). He evidenced an initial decline in narrative coherence with some degree of 
improvement from mid- to post-treatment. Orlando reported increased anxiety and tension at 
mid- and post-treatment, resulting in increased BRPS scores at these times (BPRS Total = 
+40.63%). His anxiety symptoms at mid- and post-treatment were mild to moderate (e.g. 
frequent worry, motor tension) and appeared on both occasions to be reactive to study-related 
stress. 
Insert Figure 3. 
Bernard attended 25 therapy sessions. He presented with grandiose delusions and had 
the highest BPRS Thought Disturbance score in the study at pre-treatment. His overall 
symptom severity fell within the ‘moderately ill’ range. His attendance at therapy sessions 
was inconsistent in part due to physical health problems, which resulted in him having the 
fewest therapy sessions in the study. During initial sessions, his therapist experienced 
Bernard’s narratives as grandiose, with little sense of human vulnerability. She found it 
difficult to connect with him. However, as sessions progressed and Bernard attended more 
consistently, the narratives became laced with sadness and fear; affective experiences that 
Bernard was inconsistently able to experience. The final session was uncomfortable for 
Bernard, resulting in a significant increase in grandiosity, making it difficult for his therapist 
to make a connection with him. She found it difficult to assist him in thinking about the 
difficulty of ending. Bernard showed modest improvements in narrative coherence and 
complexity over the course of therapy (NCRS = +16.67%, STAND = +8.33%; see Figure 4). 
He experienced no change in self-reflectivity. He was one of only two patients in the ‘most 
improved’ and ‘improved’ groups in which self-reflectivity did not improve. While his overall 
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level of symptom severity was unchanged at post-treatment, he did display a decrease in his 
positive schizophrenia symptoms (BPRS Thought Disturbance = –16.67%). 
Insert Figure 4. 
Improved. Five patients in the study ‘improved’ at post-treatment, with RAS score 
increases of 6 to 21 points over the course of therapy: Thomas, Dominic, Humphrey, Clancy, 
and Derek.  
Thomas attended 38 therapy sessions. He presented with slightly flat affect, motor 
retardation, and moderately severe anxiety at pre-treatment. His overall symptom severity fell 
within the ‘mildly ill’ range at pre-treatment. English was not his first language. Thomas did 
not accept biological or psychological explanations for his psychotic episodes. Instead, he 
understood his symptoms as spiritual experiences and maintained this understanding 
throughout therapy. This belief system appeared to interfere with his capacity to develop 
insight around his difficulties, e.g. negative symptoms. Notably, Thomas was more amenable 
to understanding his mood symptoms in terms of psychological and social difficulties. His 
therapist experienced sessions with Thomas as affectless and lacking in the exploration of 
multiple aspects of Thomas’s experience. Thomas was briefly hospitalised after the post-
treatment interview due to a psychotic episode but recovered quickly returning to full-time 
work after a couple of weeks. Despite notable improvements on the RAS, Thomas 
experienced one of the smallest improvements in narrative coherence and complexity in the 
study (NCRS = +9.1%, STAND = +6.7%; see Figure 5). He was also one of only two patients 
in the ‘most improved’ and ‘improved’ groups with no improvement in self-reflectivity at 
post-treatment. At post-treatment, Thomas’s depressive and anxiety symptoms had remitted, 
which likely contributed to his increased sense of recovery (BPRS Mood Disturbance = –
50%). 
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Insert Figure 5. 
Dominic attended 45 therapy sessions. He experienced daily auditory hallucinations 
and persecutory delusions. He also presented with a marked lack of agency and was often 
unable to account for his actions except in terms of following the commands of his voices, 
e.g. “I ate cereal this morning because my voices told me to”. When compared to other 
patients in the study, Dominic had the greatest overall symptom severity at pre-treatment, 
falling in the ‘markedly ill’ range. He also had the lowest RAS score pre-treatment. Initially, 
Dominic was only able to engage in 10-minute sessions, slowly working up to 25-minute 
sessions over the course of therapy. Dominic’s therapist experienced his narrative as largely 
empty and disjointed, which was consistent with how Dominic described experiencing 
himself – as if there was not a lot to him, and he did not know why he kept “trudging” on. 
Over the course of therapy, more aspects of Dominic’s self-experience emerged, albeit still in 
a disjointed way, as Dominic seemed to become more comfortable expressing himself in the 
therapeutic space. Dominic achieved notable improvements in narrative coherence and 
metacognitive capacity (NCRS = +20%, MAS-SR = +37.5%; see Figure 6). He also displayed 
an overall increase in narrative complexity, with a large improvement from pre- to mid-
treatment followed by a decrease from mid- to post-treatment (STAND = +35.3%). Dominic 
displayed less severe positive symptoms at post-treatment (BPRS Thought Disturbance = –
11.76%); although, overall symptom severity was unchanged. 
Insert Figure 6. 
Humphrey attended 52 therapy sessions. He had a 20 year history of persecutory 
delusions but was relatively free of positive schizophrenia symptoms at the beginning of 
treatment. He experienced marked negative symptoms and had the second highest BPRS 
Apathy subscale score in the study. Humphrey was relatively well-functioning and had the 
18 
highest RAS score at the beginning of treatment. His overall symptom severity fell within the 
‘mildly ill’ range at pre-treatment. Humphrey engaged readily in the therapeutic process. 
During the initial stage of therapy Humphrey’s therapist experienced sessions as devoid of 
affect with little variation in the story or emotion. However, as therapy progressed his 
therapist felt a greater sense of connection with Humphrey and his narrative as they developed 
a shared understanding of his experiences. Termination occurred at a time when Humphrey 
was dealing with the loss of a friend, and although both Humphrey and his therapist felt 
sadness at ending there was still a sense of hope and direction for the future. Humphrey 
displayed notable improvements in his reflective capacity in the first six months of treatment 
(MAS-SR = +100%; see Figure 7). He also displayed modest improvements in narrative 
complexity and coherence (STAND = +11.8%; NCRS = +6.3%). Facilitation of Humphrey’s 
understanding of his emotions (Item 4, MAS-SR) quickly led to the acquisition of higher-
order metacognitive functions, e.g., ability to recognise the limited impact that his 
expectations and desires have on reality, and ability to recognise his behaviour is influenced 
by his emotions. Improved reflective capacity occurred alongside a reduction in Humphrey’s 
negative symptoms (BPRS Apathy = –18.18%). 
Insert Figure 7. 
Clancy attended 88 therapy sessions. He had experienced paranoid delusions since 
adolescence and had one of the longest lengths of illness in the study. At pre-treatment,  he 
had one of the lowest RAS scores and one of the highest BPRS scores in the study, falling 
within the ‘moderately ill’ range. Clancy presented with a barren narrative (Lysaker & 
Lysaker, 2002) and some persecutory ideation. He was extremely socially isolated. Clancy 
attended sessions consistently for two years and had the greatest number of therapy sessions 
in the study. For the first year of treatment his therapist experienced sessions as repetitive, 
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seemingly “empty”, and lacking an enlivened dialogue between patient and therapist. The 
second year saw the establishment of a shared partnership between Clancy and his therapist 
and the development of a more flexible, lively dialogue, as new aspects of Clancy’s self-
experiences were revealed within the therapeutic dialogue. Termination appeared to be a 
difficult process for Clancy with him expressing notable anger during his final session. He 
achieved positive changes in narrative coherence, narrative complexity, and self-reflectivity 
over the course of therapy (NCRS = +50%, STAND = +11.11%, MAS-SR = +14.29%; see 
Figure 8). He also experienced an overall decrease in symptom severity (BPRS Total = –
20.75%), in particular he had less severe depression and anxiety symptoms at post-treatment 
(BPRS Mood Disturbance = –40%). Clancy was the only patient in the study to improve on 
each of the general and specific outcome measures at post-treatment. 
Insert Figure 8. 
Derek attended 50 therapy sessions. He was the youngest patient and had one of the 
shortest illness lengths in the study. He presented at pre-treatment relatively symptom-free, 
with the lowest BPRS score in the study. Derek attended sessions consistently over the course 
of treatment but struggled at times with the power differential that existed in the therapeutic 
relationship. When vulnerable he often questioned his therapist’s competence and experienced 
her as trying to make him cry or feel difficult emotions. Derek appeared to struggle greatly 
with the termination process, expressing significant anger towards his therapist in his final 
therapy session. He achieved notable improvements in narrative complexity and self-
reflectivity, particularly during the second half of therapy (STAND = +33.33%, MAS-SR = 
+40%; see Figure 9). He also reported an increased awareness and understanding of his 
emotional experiences. Despite an overall improvement on the RAS, Derek displayed a 10-
point decrease in his RAS scores from mid- to post-treatment. He also had increased 
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depressive and positive symptoms at post-treatment (mild depression, and moderate anxiety 
and suspiciousness; BPRS Total = +27.59%).   
Insert Figure 9. 
Unchanged. Two patients in the study were ‘unchanged’ at post-treatment, with RAS 
score changes of three or less points from pre- to post-treatment: Walden and Raymond. 
Walden attended 52 therapy sessions. He presented as relatively well-functioning with 
mild negative symptoms and mild depression and anxiety. His pre-treatment RAS score was 
the second highest in the study. His overall symptom severity fell within the ‘mildly ill’ range 
at pre-treatment. Walden attended his sessions relatively consistently over 14 months but 
struggled to engage with his therapist. His therapist experienced their sessions as repetitive, at 
times boring, and as if there was no need for her to be in the room. Walden also seemed to 
find it difficult to discuss parts of himself in-session that he had not pre-planned before 
arriving. However, over the year of therapy, snippets of new, more vulnerable aspects of 
Walden’s self-experience emerged as he began to feel more comfortable within the 
therapeutic relationship. Walden only experienced a three-point increase in his RAS scores 
from pre- to post-treatment. However, he displayed a notable positive change in self-
reflectively, developing a greater awareness of his emotional experiences and the subjectivity 
of his mental states (MAS-SR = 57.1%; see Figure 10). He also displayed an improvement in 
narrative complexity (STAND = +15.2%) and a slight decrease in narrative coherence (NCRS 
= –5.88%). 
Insert Figure 10. 
Raymond attended 39 therapy sessions and had the shortest length of treatment in the 
study (11 months). He presented with persecutory ideation, with his overall symptom severity 
falling in the ‘mildly ill’ range at pre-treatment. Over the course of therapy, Raymond’s 
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therapist experienced him as consumed by a strong sense of having been exploited and 
victimized, which impacted his capacity to engage in a flexible dialogue in-session. After a 
termination date was set, Raymond chose to end therapy two months early, unable to 
acknowledge that a relationship would be lost as part of the termination process. Over the 
course of therapy Raymond experienced decreases in narrative coherence, narrative 
complexity, and self-reflectivity (NCRS = –15.38%, STAND = –5.88%, MAS-SR = –30%; 
see Figure 11). He was the only patient in the study to experience decreases on all the 
treatment specific outcome measures at post-treatment. Raymond also experienced an 
increase in depression and anxiety symptoms at post-treatment (BPRS Mood Disturbance = 
+80%). Notably, his positive schizophrenia symptoms had decreased at post-treatment (BPRS 
Thought Disturbance = –37.5%). 
Insert Figure 11. 
Deteriorated. Morrison was the only patient in the study to have ‘deteriorated’ over 
the course of therapy, with a 10-point decrease in his RAS scores from pre- to post-treatment. 
Morrison attended 52 therapy sessions. He presented with grandiose delusions, inappropriate 
affect, and somewhat disorganized speech. His overall symptom severity fell within the 
‘moderately ill’ range at pre-treatment. Morrison’s therapist initially experienced him as 
child-like with him filling sessions with elaborate but incoherent narratives. The therapeutic 
process was further complicated by intense transference and countertransference reactions. 
Most notably, Morrison frequently disclosed romantic feelings towards his therapist in-
session leaving her feeling destabilized. As therapy continued his therapist experienced his 
narratives as easier to follow and somewhat more reality-based. Morrison and his therapist 
were more able to have some experiences of separateness. The process of termination was 
frightening for Morrison, although he showed resolve in being able to think about what it 
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might be like for him and what he may need to do to keep himself psychically safe. During 
the final session, Morrison was experienced by the therapist as palpably desperate, expressing 
fanciful ideas of a continuing relationship with her. Over the course of therapy, Morrison 
experienced the largest improvement in narrative coherence of all patients in the study (NCRS 
= +80%; see Figure 12). However, he displayed a decrease in narrative complexity (STAND 
= –8.57%). At post-treatment he also presented with decreased grandiosity but increased 
anxiety (BPRS Thought Disturbance = –41.67%, BPRS Mood Disturbance = +22.22%). 
Insert Figure 12. 
 
Discussion 
The current study demonstrates the feasibility and value of implementing an 
innovative psychological intervention for a group of people who have previously been 
considered “untreatable”. Despite claims of the chronic nature of schizophrenia, research 
shows that many sufferers achieve meaningful degrees of recovery from the disorder and that 
the recovery process can be facilitated by promoting metacognitive capacity (Buck & 
Lysaker, 2009; Davidson & McGlashan, 1997; Lysaker, et al., 2007; Salvatore, et al., 2012). 
The results of the current study strongly support this assertion. Based on the largest cohort to 
date, current findings demonstrate that the manualized version of Metacognitive Narrative 
Psychotherapy results in positive outcomes for people with schizophrenia. Subjective sense of 
recovery and self-reflectivity improved most over the course of therapy, with medium to large 
effect sizes and significant differences between group means at pre- and post-treatment. These 
findings indicate the approach’s utility in improving self-experience and facilitating recovery 
in sufferers of schizophrenia. While no group changes in symptom severity were found, 
evidence of patient improvement in subjective sense of recovery, despite ongoing psychiatric 
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symptoms, is consistent with consumer models of recovery from schizophrenia (Bellack, 
2006). Findings support the notion that Metacognitive Narrative Psychotherapy fills a gap in 
current treatment options for this population by addressing the subjective aspects of recovery 
from mental illness and improving patients’ capacity to think of themselves and their 
experiences in more meaningful ways. 
Current findings also point to the capacity of the approach to enhance patients’ 
narrative coherence and complexity overtime. Although group analyses were not significant, 
medium to large effects sizes were yielded for these treatment-specific outcomes. Qualitative 
data demonstrates the positive impact of Metacognitive Narrative Psychotherapy on patients’ 
narratives. Notably, degree of improvement in narrative coherence appears to be impacted by 
level of coherence at pre-treatment, with patients who initially presented with relatively 
coherent narratives, e.g. Orlando, Humphrey, Derek, and Walden, achieving smaller gains 
than those who presented with notable deficits in narrative coherence, e.g. Dominic, Clancy, 
and Morrison. 
Results from the current study illustrate the value of Metacognitive Narrative 
Psychotherapy in the treatment of even the most chronic sufferers of schizophrenia. Several 
patients in the study might well have been considered untreatable, presenting with extremely 
fragmented self-experience and chronic schizophrenia-related symptoms. Nevertheless, 
overtime even those patients most affected by psychiatric symptoms demonstrated 
improvement. For example, in the case of Dominic, the use of shorter therapy sessions helped 
him manage his engagement in the therapeutic process, resulting in notable positive 
outcomes; and in the case of Clancy a longer length of treatment led to improvements on all 
outcome measures. Such findings point to the need to re-examine long-standing assumptions 
about working psychotherapeutically with persons who have a long history of schizophrenia, 
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and as such be cautious when determining certain patients are not going to benefit from 
psychological interventions due to symptom severity or poor reflective capacity.  
Current results also highlight the integral role of the therapeutic relationship in 
facilitating therapeutic change in Metacognitive Narrative Psychotherapy for people with 
schizophrenia. Therapist experiences illustrated that a meaningful therapeutic relationship 
with patients with schizophrenia can be established, and that the development of a shared 
understanding between therapist and patient enhanced the patient’s ability to make use of 
interventions. Responses to termination also illustrated the crucial role of the therapeutic 
relationship in treatment, with the end of therapy evoking feelings of anger and confusion, 
fantasies of an ongoing relationship, withdrawal from therapy, and potentially an increase in 
positive schizophrenia symptoms (e.g. in the case of Derek). Qualitative findings point to the 
importance of thoughtful management of the termination process in psychotherapy with 
people with schizophrenia, especially in research trials where termination may be forced by 
treatment protocols. Future investigation of the effectiveness of Metacognitive Narrative 
Psychotherapy would benefit from the inclusion of a formal measure of therapeutic alliance, 
e.g. the Working Alliance Inventory (Horvath & Greenberg, 1989), to enhance understanding 
of the role of the therapeutic relationship in treatment outcomes for people with 
schizophrenia.  
Two issues need further attention. While there was improvement of symptoms for 
some patients, the overall findings failed to demonstrate symptom improvement at the group 
level. There was also a subgroup of patients who deteriorated on some outcome variables over 
the course of the study (e.g. Morrison). It is likely that a combination of patient factors, 
therapist qualities, and therapist-patient dynamic issues contributed to the poor response of 
some patients. Further analysis of poor responders is needed to enhance our understanding of 
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the approach’s effectiveness, e.g. what interventions help and for whom. Future trials may aid 
in the development of more nuanced ways for assessing patient appropriateness for 
Metacognitive Narrative Psychotherapy.  
Further, research suggests that accurate case formulation and interpretation of 
interpersonal patterns is associated with positive outcomes in psychotherapy (Luborsky & 
Crits-Christoph, 1998; Safran & Muran, 2000; Weiss, 1993). It is possible that variability in 
the training and competency of the therapists involved in the current study resulted in varying 
accuracy in case formulation and management of relational difficulties in-session, with poorer 
therapist sensitivity linked to poorer outcomes. Qualitative findings suggest that future studies 
utilizing the approach described would benefit from increased therapist training in case 
formulation and management of therapy relationship factors. 
The current findings demonstrate the effectiveness of Metacognitive Narrative 
Psychotherapy in enhancing recovery. Nevertheless, the generalizability of the findings is 
limited. Factors contributing to the limitations include the small sample size, lack of a control 
group, and restricted number of data collection points. However, the methodology employed 
demonstrates the feasibility of a larger, controlled trial. A larger trial with multiple assessment 
time-points would provide the opportunity to investigate the impact of the approach on other 
variables, e.g. social functioning, quality of life, and mastery, and also take better account of 
the non-linear change process. In addition, it would be appropriate for future studies to 
include a more comprehensive assessment of symptomatology utilizing the Positive and 
Negative Syndrome Scale (PANSS), as well as measures of depression and anxiety. A 
controlled trial is the necessary next step in further confirming the utility of Metacognitive 
Narrative Psychotherapy in the treatment of people with schizophrenia. 
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Table 1  
Mean, Standard Deviation, and Effect Size for Outcome Variables 
 Pre-treatment 
______________ 
Mid-treatment 
______________ 
End-treatment 
______________ 
 
 M SD M SD M SD d 
General outcome measures 
RAS 154.18 16.82 162.45 16.13 168.91 21.14 1.064* 
BPRS 40.73 9.10 39.10 8.72 41.18 7.52 - 
Specific outcome measures  
MAS-SR 4.13 0.71 4.86 1.00 5.00 1.30 .671* 
STAND 14.59 2.82 15.46 2.09 16.09 2.62 .744 
NCRS 11.91 4.46 12.18 3.64 13.20 2.97 .842 
Note. RAS = Recovery Assessment Scale. BPRS = Brief Psychiatric Rating Scale – Extended. 
NCRS = Narrative Coherence Rating Scale. STAND = Scale to Assess Narrative 
Development. MAS-SR = MAS Self-Reflectivity subscale. M = mean. SD = standard 
deviation. d = effect size. 
*p < 0.5  
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Table 2.  
Individual Case Demographics and RAS Changes Pre- to Post-Treatment  
 Patient Age Employment Relationship Status Yrs of Illness  # Sessions Months of Tx RAS 
Most Improved William Late 30s Unemployed Single 10-15 42 15 +33 pts 
 Orlando Late 30s Full-time Single 5 52 13 +32 pts 
 Bernard Late 60s Unemployed Single, parent 50+ 25 14 +32 pts 
Improved Thomas Mid 30s Full-time Married <5 38 17 +21 pts 
 Dominic Mid 50s Unemployed Single, parent 30-40 45 15 +19 pts 
 Humphrey Early 40s Part-time Single 20 52 14 +16 pts 
 Clancy Mid 60s Unemployed Single 50+ 88 26 +11 pts 
 Derek Mid 20s Student Single <5 50 15 +6 pts 
Unchanged Walden Mid 30s Full-time Single 15 52 14 +3 pts 
 Raymond Early 40s Unemployed Single 15 39 11 -1 pts 
Deteriorated Morrison Late 50s Unemployed Single 30 52 20 -10 pts 
Note. Tx = Treatment. RAS = Recovery Assessment Scale.
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Figure 1. Two pathways to impoverished self-experience in schizophrenia. Adapted from 
Psychotherapy and Recovery from Schizophrenia: A Review of Potential Applications and 
Need for Future Research (p. 83), by P. H. Lysaker, S. M. Glynn, S. M. Wilkniss, and S. M. 
Silverstein, 2010. Adapted with permission. 
 
 
Figure 2. Outcome measure scores for William pre-, mid-, and post-treatment.  
 
Figure 3. Outcome measure scores for Orlando pre-, mid-, and post-treatment.  
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Figure 4. Outcome measure scores for Bernard pre- and post-treatment. 
 
Figure 5. Outcome measure scores for Thomas pre-, mid-, and post-treatment.  
 
Figure 6. Outcome measure scores for Dominic pre-, mid-, and post-treatment.  
 
Figure 7. Outcome measure scores for Humphrey pre-, mid-, and post-treatment.  
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Figure 8. Outcome measure scores for Clancy pre-, mid-, and post-treatment.  
 
Figure 9. Outcome measure scores for Derek pre-, mid-, and post-treatment.  
 
Figure 10. Outcome measure scores for Walden pre-, mid-, and post-treatment.  
 
Figure 11. Outcome measure scores for Raymond pre-, mid-, and post-treatment.  
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Figure 12. Outcome measure scores for Morrison pre-, mid-, and post-treatment. 
 
  
 
